Jodi Devlin - 30 Aug 2023 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
President, Therapeutics
Signature
/s/ Mary Szela, Attorney-in-Fact for Jodi Devlin
Issuer symbol
TLSI
Transactions as of
30 Aug 2023
Net transactions value
$0
Form type
4
Filing time
31 Aug 2023, 21:04:03 UTC
Previous filing
31 Aug 2023
Next filing
14 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLSI Employee Stock Option (right to buy) Award $0 +195,000 $0.000000 195,000 30 Aug 2023 Common Stock 195,000 $6.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of August 28, 2023, and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the vesting commencement date.